PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of viroljBioMed CentralBiomed Central Web Sitesearchsubmit a manuscriptregisterthis articleVirology JournalJournal Front Page
 
Virol J. 2012; 9: 144.
Published online Aug 3, 2012. doi:  10.1186/1743-422X-9-144
PMCID: PMC3422167
Inaccurate identification of rotavirus genotype G9 as genotype G3 strains due to primer mismatch
Marcelo Takahiro Mitui,1 TGA Nilmini Chandrasena,2 Paul KS Chan,3 Shaman Rajindrajith,4 E Anthony S Nelson,5 Ting Fan Leung,5 Akira Nishizono,1 and Kamruddin Ahmedcorresponding author6
1Department of Microbiology, School of Medicine, Oita University, Yufu, Oita, Japan
2Department of Parasitology, Faculty of Medicine, University of Kelaniya, Ragama, Sri Lanka
3Department of Microbiology, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, People’s Republic of China
4Department of Pediatrics, Faculty of Medicine, University of Kelaniya, Ragama, Sri Lanka
5Department of Paediatrics, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, People’s Republic of China
6Research Promotion Institute, Oita University, Yufu, Oita, Japan
corresponding authorCorresponding author.
Marcelo Takahiro Mitui: tmitsui/at/oita-u.ac.jp; TGA Nilmini Chandrasena: nilmini/at/mfac.kln.ac.lk; Paul KS Chan: paulkschan/at/cuhk.edu.hk; Shaman Rajindrajith: shamanr0/at/lycos.com; E Anthony S Nelson: tony-nelson/at/cuhk.edu.hk; Ting Fan Leung: tfleung/at/cuhk.edu.hk; Akira Nishizono: a24zono/at/oita-u.ac.jp; Kamruddin Ahmed: ahmed/at/oita-u.ac.jp
Received December 7, 2011; Accepted July 30, 2012.
Reverse transcription (RT)-PCR is now the standard method for typing group A rotaviruses (RVA) to monitor the circulating genotypes in a population. Selection of primers that can accurately type the circulating genotypes is crucial in the context of vaccine introduction and correctly interpreting the impact of vaccination on strain distribution. To our knowledge this study is the first report from Asia of misidentification of genotype G9 as G3 due to a primer-template mismatch. We tested two published G-genotype specific primers sets, designed by Gouvea and colleagues (Set A) and Iturriza‐Gomara and colleagues (Set B) on RVA from Hong Kong and Sri Lanka. Among 52 rotaviruses typed as G3 by set A primers, 36 (69.2%) were identified as G9 by nucleotide sequencing and set B primers. Moreover, of 300 rotaviruses tested, 28.3% were untypable by set A primers whereas only 12.3% were untypable by set B primers. Our findings reinforce the need to periodically monitor the primers used for RVA genotyping.
Keywords: Group a rotavirus, Genotyping, Primer mismatch, Genotype G3, Genotype G9, Hong Kong, Sri Lanka
Every year rotavirus infects 114 million children and accounts for about 453,000 deaths mainly in developing countries [1,2]. RVA is a non-enveloped virus with a triple-layered wheel-like capsid containing 11 segments of double stranded RNA in its core. VP7 and VP4 nucleotide sequence define the G and P genotypes, respectively [3]. These proteins have independent neutralization properties and are used in a binary classification system. Of the 27 G and 35 P types thus far identified by molecular characterization [4], 12 G and 15 P types have been detected in humans [3]. Globally, G1 through G4 and G9 are the most common types causing human infection [5]. The primary goal of most RVA strain surveillance has been to determine the circulating genotypes for the introduction of vaccine and to monitor vaccine effectiveness [6].
RT-PCR is the method of choice for typing rotaviruses and is regarded as the gold standard [7]. The accumulation of point mutations at primer binding sites has been linked with mistyping or failure to identify genotype correctly. To maintain the accuracy, primers used in PCR-based typing methods need to be regularly revised and updated [8]. In 1990, a multiplexed hemi-nested RT-PCR based G genotyping assay was developed by Gouvea and colleagues [9]. This assay, correlated well with an antibody-based G-serotyping system. Subsequently, primers proposed by Das et al. [10] and Iturriza-Gómara et al. [11] for G genotyping assays were introduced.
In our laboratory we used primers designed by Gouvea et al., for genotyping RVA from different countries and satisfactory results were obtained when RT-PCR results were compared with VP7 gene sequence information. We regularly validated the results of PCR with VP7 sequence results and, during genotyping of RVA from Sri Lankan samples, it was identified that many of the genotype G9 rotaviruses were typed as G3 by PCR.
G9 strains started to be reported in the mid-1990s from India, Japan, the United Kingdom, and the United States [12]. Subsequently, these strains spread globally and they are now the third most common genotype of RVA. In recent years the G9 rotaviruses have also shown increasing genomic diversity within the genotype [13].
An overall increase in G3 strains has recently being reported from many countries [14-16], some of them in association with the introduction of the pentavalent RVA vaccine [17,18]. How vaccine pressure has resulted in emergence of this genotype is unknown, but sustained and accurate monitoring is clearly desirable to clarify this.
Since both G9 and G3 are very important considering the current epidemiology of genotype distribution, we extended the experiment to all samples from Sri Lanka and Hong Kong and determined that alternate primers set designed by Iturriza-Gomara et al. (2004) [11] gave us satisfactory results. Considering the importance of this finding we are reporting the results to aware researchers.
A total of 422 stool samples positive for RVA were obtained from children under 5 years of age who attended major hospitals in Hong Kong and Sri Lanka for diarrhea: 300 from Hong Kong (December 2004 through December 2005); 122 from Sri Lanka (April 2005 through October 2006). These samples were collected as part of rotavirus surveillance [14,19]. Approval was obtained from the Ethical Review Board of Sri Lankan College of Pediatrics. Hong Kong samples were the remaining portion of specimens submitted for tests because of clinical indication, therefore approval was not required. All samples were delinked from personal identifiers.
RVA was detected using the commercially available ELISA kits according to manufacturer’s instructions: IDEIA Rotavirus (Dako Diagnostics, Cambridgeshire, UK) in Hong Kong; and Rotaclone (Meridian Bioscience Inc., Cincinnati, OH) in Sri Lanka. The nucleic acids were extracted by the phenol- chloroform-isoamyl alcohol method.
We used one step RT-PCR targeting the VP7 gene of RVA. PCR primers were Beg9 and End9 [9]. A commercial master mix formulation, AccessQuick™ RT-PCR System (Promega Corporation, Madison, WI, USA) was employed. Each reaction contained 25 μl of AccessQuick™ Master Mix, 1 μl of each primer at a final concentration of 0.2 μM, 2 μl of the dsRNA template, 1 μl of reverse transcriptase, and nuclease-free water to a final volume of 50 μl. For RT, incubation was at 45°C for 45 minutes and the contiguous PCR conditions were as follows: 95°C for 1 minute, followed by 40 cycles at 94°C for 1 minute, 50°C for 1 minute, 72°C for 1 minute 30 seconds and a final extension at 72°C for 5 minutes.
In this study, the G type was identified by hemi-nested multiplex PCR method with genotype specific primers for G1, G2, G3, and G4 proposed by Gouvea et al. [9] (designated “set A”) and by nested multiplex PCR method with genotype specific primers for G1, G2, G3, G4 and G9 proposed by Iturriza-Gómara et al. [11] (designated “set B”)(Table 1). For both sets of primers, PCR was carried out by the PCR Master Mix (Promega Corporation), as follows: each reaction contained 25 μl of PCR Master Mix, 1 μl of each primer at a final concentration of 0.2 μM, 1 μl of the VP7 amplicon, and nuclease-free water to a final volume of 50 μl. PCR conditions were as follows: 30 cycles at 95°C for 1 minute, 42°C for 2 minutes and 72°C for 1 minutewith a final extension step at 72°C for 5 minutes.
Table 1
Table 1
Primer comparison between Gouvea et al. and Iturriza-Gomara et al. Note that primer for G3 and G9 are different
The nucleotide sequence of the VP7 gene was determined by Big Dye terminator v3.1 cycle sequencing kit (Applied Biosystems, Foster city, CA, USA) and the product was subjected to an ABI Prism 3130 Genetic Analyzer (Applied Biosystems) [12]. The VP7 gene sequence similarity was searched by BLAST to determine the G types. The genotype of each strain determined by different sets of primers was compared with corresponding nucleotide sequence.
Of the 52 RVA typed as G9 by nucleotide sequencing of the VP7 gene, 36 (69.2%) (3 from Hong Kong and 33 from Sri Lanka) were typed as G3 by set A primers.
To determine the identity between the primers and the nucleotide sequences of the gene, the G3 and G9 primers of both set A and B were aligned with the nucleotide sequence of the VP7 gene of G9 strains (3 from Hong Kong and 22 from Sri Lanka) (Figure (Figure1).1). The G3 and G9 primers of set A showed 76% (16/21nt) and 85% (17/20nt) identity, whereas the G3 and G9 primers of set B had 58% (11/19nt) and 100% (20/20) identity, respectively.
Figure 1
Figure 1
Multiple alignments of the VP7 gene sequences of G9 rotaviruses from Hong Kong and Sri Lanka with the corresponding G3 and G9 specific primers proposed by Gouvea et al. and Iturriza-Gómara et al. Dots indicate consensus with the primer
Aligning the G3 primers of set A with the VP7 gene sequences of G9 strains revealed eight consecutive nucleotide identities in the middle and three consecutive nucleotide identities next to the 3′ end. This could explain the mismatched primer binding and as a consequence the incorrect genotyping.
G3 forward primer of set A was derived from residues 689 to 709 nt of the VP7 gene of G3 RVA generating a PCR product of 374 bp, but it also anneals with the same residues of the VP7 gene of G9 RVA, generating a PCR product of the same length and indistinguishable after running the gel electrophoresis. G3 forward primer of set B was derived from residues 250 to 269 nt of the VP7 gene of G3 rotavirus generating a PCR product of 682 bp.
To verify the accuracy of set B primers, typing was done on five G9 and five G3 strains. The types of these strains were confirmed by nucleotide sequencing. All were typed correctly by set B primers but identified as genotype G3 by set A primers.
A total of 300 rotaviruses arbitrarily selected from Hong Kong were subjected to typing by both sets of primers, 80 strains were typed as G3 by both sets of primers. However, nine G9 strains typed as G3 by set A primers were correctly typed by set B primers, showing a 10.1% chance of mistyping (G9 as G3) by set A primers. Of 300 rotaviruses tested, 28.3% were untypable by set A primers whereas only 12.3% were untypable by set B primers. These untypables were typed by the VP7 gene sequencing and no primer mismatch was found indicating possible contaminants which hindered PCR.
RT-PCR genotyping failure is a hindrance in RVA research, generally ranging 10–30%, and tends to be higher in samples from developing countries [20]. This problem has often been attributed to single nucleotide polymorphisms at the primer binding sites [21-25]. The occurrence of erroneous typing among strains due to mismatched primers deserves special consideration. Reported RVA primers mismatches identified genotype G8 as G12 and G3 as G10 [25-27]. To our knowledge this is the first report from Asia of G9 being mistyped as G3 [28], since both are prevalent genotypes worldwide, this information will be crucial for accurate surveillances.
Gouvea et al. [9] and Iturriza-Gómara et al. [11] proposed the primers for G genotyping in 1990 and 2004, respectively. It is plausible that rotaviruses have high mutation rates even in sites that are considered well conserved. It is therefore essential that widely used primers sets, particularly those developed some while back, be re-evaluated on a regular basis to ensure that circulating RVA strains are accurately typed.
Competing interests
P. K. S. Chan participated in vaccine studies funded by Baxter, GlaxoSmithKline and MedImmune, and received travel support from GlaxoSmithKline, Merck and Roche. E. A. S. Nelson has received funding from Merck and Pfizer (Wyeth) for diarrhoeal and respiratory disease surveillance studies, has participated in vaccine studies funded by Baxter, GlaxoSmithKline, MedImmune and Wyeth, including a Phase III Rotarix study, and has received lecture fees and travel support from GlaxoSmithKline, Merck, Intercell and Pfizer (Wyeth). Other authors have no conflict of interest.
Authors’ contributions
Conceived and designed the experiments: MTM, KA. Performed the experiments: MTM, TGANC, CPKS, SR, TFL. Analyzed the data: MTM, KA, AN. Wrote the paper: MTM, KA, CPKS, EASN. All the authors have read and approved the final manuscript.
Acknowledgments
This study was supported by the Research Fund at the Discretion of the President, Oita University [610000-N5010] to K. A.
  • Tate JE, Burton AH, Boschi-Pinto C, Steele AD, Duque J, Parashar UD. Network W-cGRS. 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis. 2012;12:136–141. doi: 10.1016/S1473-3099(11)70253-5. [PubMed] [Cross Ref]
  • Chandran A, Fitzwater S, Zhen A, Santosham M. Prevention of rotavirus gastroenteritis in infants and children; rotavirus vaccine safety, efficacy, and potential impact of vaccines. Biologics. 2010;4:213–229. [PMC free article] [PubMed]
  • Greenberg H, Estes M. Rotaviruses: from pathogenesis to vaccination. Gastroenterology. 2009;136:1939–1951. doi: 10.1053/j.gastro.2009.02.076. [PubMed] [Cross Ref]
  • Matthijnssens J, Ciarlet M, McDonald SM, Attoui H, Bányai K, Brister JR, Buesa J, Esona MD, Estes MK, Gentsch JR. et al. Uniformity of rotavirus strain nomenclature proposed by the Rotavirus Classification Working Group (RCWG) Arch Virol. 2011;156:1397–1413. doi: 10.1007/s00705-011-1006-z. [PMC free article] [PubMed] [Cross Ref]
  • Glass R, Parashar U, Bresee J, Turcios R, Fischer T, Widdowson M, Jiang B, Gentsch J. Rotavirus vaccines: current prospects and future challenges. Lancet. 2006;368:323–332. doi: 10.1016/S0140-6736(06)68815-6. [PubMed] [Cross Ref]
  • Leite JP, Alfieri AA, Woods PA, Glass RI, Gentsch JR. Rotavirus G and P type scirculating in Brazil: characterization by RT-PCR, probe hybridization, and sequence analysis. Arch Virol. 1996;141:2365–2374. doi: 10.1007/BF01718637. [PubMed] [Cross Ref]
  • Fischer T, Gentsch J. Rotavirus typing methods and algorithms. Rev Med Virol. 2004;14:71–82. doi: 10.1002/rmv.411. [PubMed] [Cross Ref]
  • Masendycz P, Palombo E, Gorrell R, Bishop R. Comparison of enzyme immunoassay, PCR, and type-specific cDNA probe techniques for identification of group A rotavirus gene 4 types (P types) J Clin Microbiol. 1997;35:3104–3108. [PMC free article] [PubMed]
  • Gouvea V, Glass R, Woods P, Taniguchi K, Clark H, Forrester B, Fang Z. Polymerase chain reaction amplification and typing of rotavirus nucleic acid from stool specimens. J Clin Microbiol. 1990;28:276–282. [PMC free article] [PubMed]
  • Das B, Gentsch J, Cicirello H, Woods P, Gupta A, Ramachandran M, Kumar R, Bhan M, Glass R. Characterization of rotavirus strains from newborns in New Delhi, India. J Clin Microbiol. 1994;32:1820–1822. [PMC free article] [PubMed]
  • Iturriza-Gómara M, Kang G, Gray J. Rotavirus genotyping: keeping up with an evolving population of human rotaviruses. J Clin Virol. 2004;31:259–265. doi: 10.1016/j.jcv.2004.04.009. [PubMed] [Cross Ref]
  • Arista S, Vizzi E, Migliore MC, Di Rosa E, Cascio A. High incidence of G9P181 rotavirus infections in Italian children during the winter season 1999–2000. Eur J Epidemiol. 2003;18:711–714. [PubMed]
  • Bozdayi G, Dogan B, Dalgic B, Bostanci I, Sari S, Battaloglu N, Rota S, Dallar Y, Nishizono A, Nakagomi O, Ahmed K. Diversity of human rotavirus G9 among children in Turkey. J Med Virol. 2008;80:733–740. doi: 10.1002/jmv.21120. [PubMed] [Cross Ref]
  • Mitui MT, Chan PKS, Nelson EAS, Leung TF, Nishizono A, Ahmed K. Co-dominance of G1 and emerging G3 rotaviruses in Hong Kong: A three-year surveillance in three major hospitals. J Clin Virol. 2011;50:325–333. doi: 10.1016/j.jcv.2011.01.008. [PubMed] [Cross Ref]
  • Chan-it W, Thongprachum A, Dey SK, Phan TG, Khamrin P, Okitsu S, Nishimura S, Kobayashi M, Kikuta H, Baba T. et al. Detection and genetic characterization of rotavirus infections in non-hospitalized children with acute gastroenteritis in Japan, 2007–2009. Infect Genet Evol. 2011;11:415–422. doi: 10.1016/j.meegid.2010.11.018. [PubMed] [Cross Ref]
  • Ngo TC, Nguyen BM, Dang DA, Nguyen HT, Nguyen TT, Tran VN, Vu TT, Ogino M, Alam MM, Nakagomi T. et al. Molecular epidemiology of rotavirus diarrhoea among children in Haiphong, Vietnam: the emergence of G3 rotavirus. Vaccine. 2009;27(Suppl 5):F75–F80. [PubMed]
  • Hull JJ, Teel EN, Kerin TK, Freeman MM, Esona MD, Gentsch JR, Cortese MM, Parashar UD, Glass RI, Bowen MD, System NRSS. United States rotavirus strain surveillance from 2005 to 2008: genotype prevalence before and after vaccine introduction. Pediatr Infect Dis J. 2011;30:S42–S47. [PubMed]
  • Kirkwood CD, Boniface K, Barnes GL, Bishop RF. Distribution of rotavirus genotypes after introduction of rotavirus vaccines, Rotarix® and RotaTeq®, into the National Immunization Program of Australia. Pediatr Infect Dis J. 2011;30:S48–S53. [PubMed]
  • Ahmed K, Batuwanthudawe R, Chandrasena TGAN, Mitui MT, Rajindrajith S, Galagoda G, Pun SB, Uchida R, Kunii O, Moji K. et al. Rotavirus infections with multiple emerging genotypes in Sri Lanka. Arch Virol. 2010;155:71–75. doi: 10.1007/s00705-009-0552-0. [PubMed] [Cross Ref]
  • Gentsch J, Laird A, Bielfelt B, Griffin D, Banyai K, Ramachandran M, Jain V, Cunliffe N, Nakagomi O, Kirkwood C. et al. Serotype diversity and reassortment between human and animal rotavirus strains: implications for rotavirus vaccine programs. J Infect Dis. 2005;192(Suppl 1):S146–S159. [PubMed]
  • Adah M, Rohwedder A, Olaleyle O, Werchau H. Nigerian rotavirus serotype G8 could not be typed by PCR due to nucleotide mutation at the 3' end of the primer binding site. Arch Virol. 1997;142:1881–1887. doi: 10.1007/s007050050206. [PubMed] [Cross Ref]
  • Espínola E, Parra G, Russomando G, Arbiza J. Genetic diversity of the VP4 and VP7 genes affects the genotyping of rotaviruses: analysis of Paraguayan strains. Infect Genet Evol. 2008;8:94–99. doi: 10.1016/j.meegid.2007.08.003. [PubMed] [Cross Ref]
  • Griffin D, Nakagomi T, Hoshino Y, Nakagomi O, Kirkwood C, Parashar U, Glass R, Gentsch J. Characterization of nontypeable rotavirus strains from the United States: identification of a new rotavirus reassortant (P2A[6], G12) and rare P3[9] strains related to bovine rotaviruses. Virology. 2002;294:256–269. doi: 10.1006/viro.2001.1333. [PubMed] [Cross Ref]
  • Rahman M, Sultana R, Podder G, Faruque A, Matthijnssens J, Zaman K, Breiman R, Sack D, Van Ranst M, Azim T. Typing of human rotaviruses: nucleotide mismatches between the VP7 gene and primer are associated with genotyping failure. Virol J. 2005;2:24. doi: 10.1186/1743-422X-2-24. [PMC free article] [PubMed] [Cross Ref]
  • Aladin F, Nawaz S, Iturriza-Gómara M, Gray J. Identification of G8 rotavirus strains determined as G12 by rotavirus genotyping PCR: updating the current genotyping methods. J Clin Virol. 2010;47:340–344. doi: 10.1016/j.jcv.2010.01.004. [PubMed] [Cross Ref]
  • Santos N, Lima R, Pereira C, Gouvea V. Detection of rotavirus types G8 and G10 among Brazilian children with diarrhea. J Clin Microbiol. 1998;36:2727–2729. [PMC free article] [PubMed]
  • El-Attar L, Dhaliwal W, Iturriza-Gómara M, Bridger JC. Identification and molecular characterization of a bovine G3 rotavirus which causes age-independent diarrhea in cattle. J Clin Microbiol. 2002;40:937–942. doi: 10.1128/JCM.40.3.937-942.2002. [PMC free article] [PubMed] [Cross Ref]
  • Santos N, Volotão EM, Soares CC, Albuquerque MC, da Silva FM, Chizhikov V, Hoshino Y. VP7 gene polymorphism of serotype G9 rotavirus strains and its impact on G genotype determination by PCR. Virus Res. 2003;93:127–138. doi: 10.1016/S0168-1702(02)00318-0. [PubMed] [Cross Ref]
Articles from Virology Journal are provided here courtesy of
BioMed Central